Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Boundless Bio Inc. (BOLD)

October 24, 2025 6:52 AM EDT Send to a Friend
H.C. Wainwright analyst Mitchel Kapoor reiterated a Buy rating and $4.00 price target on Boundless Bio Inc. (NASDAQ: BOLD).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login